Company intelligence / Profile preview
Celligenics
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
Overview
Celligenics is a Singapore-based biotechnology company specializing in regenerative medicine through its proprietary cell-free secretome technology. The company focuses on harnessing the therapeutic potential of stem cell-derived secretomes, which contain a rich mix of growth factors and exosomes, to treat various conditions without the complexities of live cell transplantation. Their primary therapeutic areas include chronic wound healing, particularly diabetic foot ulcers, as well as aesthetics and musculoskeletal disorders. By utilizing a standardized and scalable manufacturing process, Celligenics aims to provide off-the-shelf regenerative solutions that are safer and more cost-effective than traditional stem cell therapies. The company's approach bridges the gap between advanced stem cell research and practical clinical applications in dermatology and orthopedics.
- Therapeutic areas
- RheumatologyEndocrinologyDermatology
- Modalities
- Exosome-based therapyCell-free therapyBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Celligenics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celligenics.